Brief: Lakewood-Amedex Biotherapeutics Announces Positive Antimicrobial Resistance Data For Lead Candidate Targeting Infected Diabetic Foot Ulcers

Lakewood-amedex Biotherapeutics

01/05/2026 14:33

May 1 (Reuters) - Lakewood-amedex Biotherapeutics Inc LABT.O:

LAKEWOOD-AMEDEX BIOTHERAPEUTICS ANNOUNCES POSITIVE ANTIMICROBIAL RESISTANCE DATA FOR LEAD CANDIDATE TARGETING INFECTED DIABETIC FOOT ULCERS

LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC - NU-3 DEMONSTRATES LOW RESISTANCE DEVELOPMENT COMPARED TO CIPROFLOXACIN IN LABORATORY STUDIES

LAKEWOOD-AMEDEX BIOTHERAPEUTICS INC - NU-3 MAINTAINS ACTIVITY AGAINST CIPROFLOXACIN-RESISTANT BACTERIA

Source text: ID:nPn5sSxw9a

Further company coverage: LABT.O

 ((Reuters.Briefs@thomsonreuters.com;))